0
Preliminary Program
Preliminary Program: TUESDAY MAY24
Psychiatric News
Volume 40 Number 4 page 26-45

7 a.m.-8:30 a.m.

Industry-Supported Breakfast Symposia IS31. Agitation and Psychosis in Alzheimer's Disease and Parkinson's Disease (Part 2)Supported by AstraZeneca Pharmaceuticals

A. Efficacy and Tolerability of Atypical Antipsychotics in Agitation and Psychosis: Clinical Applications Jeanne Jackson-Siegel, M.D.

B. Treatment of Psychosis in Parkinson's Disease Jeffrey L. Cummings, M.D.

IS32. Managing the Spectrum of Bipolar Disorder: Minimizing the Burden of Disease (Part 2)Supported by Bristol-Myers Squibb Company

A. The Impact of Safety and Tolerability on Patient Satisfaction With Therapy Paul E. Keck Jr., M.D.

B. Impact of Bipolar Maintenance Therapy on Patient Outcomes Lori L. Altshuler, M.D.

IS33. Advances in the Treatment of Mood and Anxiety Disorders in Women (Part 2)Supported by Wyeth Pharmaceuticals

A. Perinatal Consequences of Mood and Anxiety Disorders Kimberly A. Yonkers, M.D.

B. Menopausal Transition: Impact on Mood, Sleep, and Quality of Life Claudio N. Soares, M.D.

C. Managing Bipolar Disorder in Women Lesley M. Arnold, M.D.

7:30 a.m.-6 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 59-65

9 a.m.-10:30 a.m.

Clinical Case Conference 2.Elisabeth J.S. Kunkel, M.D., Angel Angelov, M.D., Larissa Chism, M.D., Dimitri D. Markov, M.D., on Consultation-Liaison Casebook Challenge: Strategies and Limitations in Establishing Competency (for APA members only)

+

9. Pedro Ruiz, M.D., on The Role of Culture in Psychiatric Practice (for residents only)

10. K. Ranga R. Krishnan, M.D., on Psychiatric Diagnosis: Approaches in the Post-Genomic Era Collaborative Session With the National Institute of Mental Health

11. Katherine L. Wisner, M.D., on Postpartum Mood Disorders

12. Ronald W. Pies, M.D., on The Great Bipolar Depression Controversy: A Pragmatic Approach (Meet the Authors)

Lectures

L10. From Genes to Therapeutics: New Approaches to SchizophreniaRobert Freedman, M.D., Distinguished Psychiatrist Lecture Series; Collaborative Session With the National Institute of Mental Health

L11. Leadership Through Example: Mentorship and Networking(Presented by Russell Lim, M.D.) K. Patrick Okura, Ph.D., APA's Kun-Po Soo Award Lecture

Master Educator Clinical Consultations

5. Harold Kudler, M.D., on PTSD and Deployment Mental Health (for APA members only)

6. John D. Wynn, M.D., on Psychosomatics and the Medically Complex Patient: Sorting Out Axis I, II, and III (for APA members only)

Round-Table Discussion on Safety and Efficacy of SSRI Antidepressants in Children and Adolescents: What Do We Know and When Did We Know It?Moderator: Richard E. D'Alli, M.D.

+

CW18. "Y" Psychotherapy: An Integrated, Evidence-Based Psychotherapy Competency ModelAPA Committee on Psychotherapy by Psychiatrists; Co-Chairpersons: Eric M. Plakun, M.D., Lisa A. Mellman, M.D.

CW19. Patient Safety: Evaluating an Adverse Event and Implementing SafeguardsAPA Committee on Patient Safety; Chairperson: Paul R. McHugh, M.D.

CW20. Closing Practice: What Every Psychiatrist's Office and His/Her Family Should KnowAPA Corresponding Committee on Physician Health, Illness, and Impairment; Chairperson: John A. Fromson, M.D.

CW21. Novel Careers in Psychiatry: Women Who Have Made Their Own WayAPA Committee on Women; Co-Chairpersons: Melva I. Green, M.D., Carrie L. Ernst, M.D.

CW22. Reversing the Criminalization of the Seriously Mentally IllAPA Corresponding Committee on Jails and Prisons; Chairperson: Henry C. Weinstein, M.D.

CW23. Disaster Psychiatry: Challenges and Novel Strategies for Residency TrainingAPA Committee on Psychiatric Dimensions of Disasters; Co-Chairpersons: Diane E. McLean, M.D., Anthony T. Ng, M.D.

CW24. Ethnicity, Culture, and Response to Disaster Among HispanicsAPA Committee of Hispanic Psychiatrists; Chairperson: Eugenio M. Rothe, M.D.

CW25. Suicide Among Ethnic EldersAPA Committee on Ethnic Minority Elderly; Co-Chairpersons: Iqbal Ahmed, M.D., Warachal E. Faison, M.D.

CW26. Using the HIV Dementia Scale in the Clinical SettingAPA Committee on AIDS; Chairperson: Karl Goodkin, M.D.

+

IW27. Are There Limits to Boundary Limits?Chairperson: Malkah T. Notman, M.D.

IW28. Children of Psychiatrists: Listen and LearnCo-Chairpersons: Leah J. Dickstein, M.D., Michelle B. Riba, M.D.

IW29. ABPN and APA Perspectives on Maintenance of CertificationChairperson: Stephen C. Scheiber, M.D.

IW30. How to Launch a Successful Private Practice (Part 1)Co-Chairpersons: William E. Callahan Jr., M.D., Keith W. Young, M.D.

IW31. Pain Management of the Chemically Dependent PatientChairperson: Jeffrey A. Berman, M.D.

IW32. Strategies for Success for Early Career Academic Psychiatrists (Part 1): Writing for PublicationChairperson: Laura W. Roberts, M.D.; Collaborative Session With the National Institute of Mental Health

IW33. Decisional Capacity in the Consultation-Liaison Setting: Controversies and DifficultiesChairperson: Ramaswamy Viswanathan, M.D.

IW34. Psychiatric Hospice on an ACT Team: When Mental Illness Is TerminalCo-Chairpersons: Curtis N. Adams Jr., M.D.. Ann L. Hackman, M.D.

IW35. Detection of Malingering in Disability EvaluationsChairperson: Roger Z. Samuel, M.D.

IW36. Teaching Psychosomatic Medicine for Primary Care Physicians: What, How, and Where?Chairperson: Hoyle Leigh, M.D.

IW37. Shakespeare, Psychiatry, and PsychopathologyChairperson: Steven E. Pflanz, M.D.

IW38. Uncovering Medical Causes of Functional Decline in the Developmentally DisabledChairperson: Stephen M. Soltys, M.D.

IW39. Drug Companies in Training Clinics: Economic Necessity Versus Undue InfluenceCo-Chairpersons: Edward A. Volkman, M.D., Ruth M. Lamdan, M.D.

IW40. Driving Miss DaisyCo-Chairpersons: Theron C. Bowers Jr., M.D., Sheila M. Loboprabhu, M.D.

IW41. Psychiatrists Intervening Upstream: Good Practices for Preventing Violence in Children, Youth, and FamiliesChairperson: Guiseppe Raviola, M.D.; Collaborative Session With the National Institute of Mental Health

IW42. Cultural Competence in the Clinical Encounter: Irma Bland and Evelyn LeeChairperson: Francis G. Lu, M.D.

IW43. A New Model for the Treatment of Relational DisordersCo-Chairpersons: Glenn N. Siegel, M.D., Mary Pittman, M.S.

9 a.m.-11a.m.

Research Advances in Medicine

Exploring New Frontiers and Clinical ApplicationsChairperson: Charles B. Nemeroff, M.D.; Co-Chairperson: Marian I. Butterfield, M.D.

9 a.m.-Noon

Continuous Clinical Case Conference 1.Eva M. Szigethy, M.D., John Campo, M.D., David DeMaso, M.D., Eyal Shemesh, M.D., on Control What You Can: Successful Treatment of Teenagers in Chronic Pain (Part 2) (for APA members only)

+

MW4. "Jim in Bold": Gay, Lesbian, and Transgender Teens on FilmAmerican Academy of Child and Adolescent Psychiatry's Sexual Orientation Committee; Co-Chairpersons: Richard R. Pleak, M.D., Sara E. Herbert, M.D.

MW5. Long-Term Management of Schizophrenia in the Film "Out of the Shadow"Co-Chairpersons: Stephen M. Goldfinger, M.D., Susan E. Smiley, B.S.

MW6. Intergenerational Family Abuse: A Documentary FilmChairperson: Barry Herman, M.D.

9 a.m.-12:30 p.m.

Advances in Psychosomatic Medicine Psychiatric Care of the Medically IllAmerican Psychiatric Publishing Inc. Editorial Board; Chairperson: James L. Levenson, M.D.

9 a.m.-4 p.m.

CME Courses 66-72

10 a.m.-6 p.m.

Exhibits Open (last day)

APA Member Center Open (last day)

Publishers' Bookfair Open (last day)

11 a.m.-12:30 p.m.

+

13. Joel Yager, M.D., on Career Building in Academic and Nonacademic Psychiatry (for residents only)

14. Tana A. Grady-Weliky, M.D., on Effective Teaching: What Psychiatry Residents Need to Know

15. John A. Chiles, M.D., on Assessment and Treatment of Suicidal Patients (Meet the Authors)

Lectures

L12. Psychiatry in the Genomic EraThomas R. Insel, M.D., APA's Judd Marmor Award Lecture; Collaborative Session With the National Institute of Mental Health

L13. To Be AnnouncedAPA's Patient Advocacy Award Lecture

Master Educator Clinical Consultations

7. Josepha A. Cheong, M.D., on Geriatric Psychiatry (for APA members only)

8. Silvia W. Olarte, M.D.(for APA members only)

Medical Update 2.Sara Berga, M.D., on Stress-Induced Anovulation: Mind Over Matter

Research Consultation 2.Helen S. Mayberg, M.D., on Functional Neuroimaging Strategies in Affective Disorders Research Collaborative Session With the National Institute of Mental Health

Scientific and Clinical Report Sessions

Session 10. Epidemiology and Other Issues in Psychiatry

29. Parental Separation at Birth and Schizophrenia and Depression Pirjo H. Maki, M.D.

30. Parental Separation at Birth and Substance-Use Disorder Juha M. Veijola, Ph.D.

31. Pica Syndrome: Review and Relevance Jambur V. Ananth, M.D.

Session 11. Somatic Therapies

32. The Impact of Electroconvulsive Therapy on Quality of Life and Function W. Vaughn McCall, M.S.

33. Seizures Targeted to Circuitry: New Forms of Convulsive Therapy Sarah H. Lisanby, M.D.; Collaborative Session With the National Institute of Mental Health

34. Ethical and Legal Implications of Psychiatric Evaluation of Pediatric Gastric Bypass Gagan Dhaliwal, M.D.

Session 12. Cognitive Disorders

35. Is Depression a Risk Factor for Cognitive Impairment? A Meta-Analysis of 20 Cohort Studies Alex J Mitchell, M.D.

36. Treatment of Agitation and Psychosis in Elderly Patients With Dementia Pierre N. Tariot, M.D.

37. Prevalence of Dementia in a Southern-European Population in Two Different Time Periods Pedro Saz, M.D.

Session 13. Psychosomatic Medicine

38. Somatization Increases Medical Care Utilization and Costs Arthur J. Barsky, M.D.

39. The Integrated Management of Medically Unexplained Symptoms Donald Bakal, Ph.D.

40. Medical and Psychiatric Comorbidities of a Substance-Abusing Public-Assistance Population Bruce J. Schwartz, M.D.

Session 14. Biological Psychiatry and Neuroscience

41. Brainstem Control of Neurotic and Psychotic Processes Jacques St. Laurent, M.D.

42. Brain Stimulation: Why, Where, and How? Harold A. Sackeim, Ph.D.; Collaborative Session With the National Institute of Mental Health

43. New Findings on Daily Prefrontal Repetitive Transcranial Magnetic Stimulation for Depression Mark S. George, M.D.; Collaborative Session With the National Institute of Mental Health

Session 15. Aspects of Bipolar Disorder

44. Negative Impact of Medical Comorbidity on the Course of Bipolar Disorder Dan V. Iosifescu, M.D.; Collaborative Session With the National Institute of Mental Health

45. Lithium Continuation/Discontinuation After Four Years of Stability Eric D. Peselow, M.D.

46. Magnitude of the Effects of Quetiapine Treatment in Bipolar Disorder Wayne Macfadden, M.D.

Session 16. Child and Adolescent Psychopharmacology

47. Pediatric Formulation of Modafinil Effective in Children and Adolescents With ADHD James M. Swanson, M.D.

48. Modafinil Pediatric Formulation Has Early and Sustained Effect in ADHD Joseph Biederman, M.D.

49. Polypharmacy Among Youths: How Prevalent Is It? Farifteh F. Duffy

Session 17. PTSD and Anxiety

50. PTSD Depression and Anger in Patients Recovered From SARS Rima Styra, M.D.

51. Are Anxiety Disorders Underdiagnosed and Undertreated in Psychiatry? Joshua E. Wilk, Ph.D.

52. Biological Findings in PTSD: Can They Be Changed by Psychotherapy? Friedhelm Lamprecht, M.D.

Session 18. Issues in Biological Psychiatry

53. The Family Genetic Study of Pathological Gambling Donald W. Black, M.D.

54. Metabolic Syndrome in Psychiatric Inpatients Receiving Antipsychotics John W. Goethe, M.D.

55. Anorexia Nervosa and Bulimia Nervosa: From Culture to Genes Pamela K. Keel, Ph.D.; Collaborative Session With the National Institute of Mental Health

+

CW27. Benzodiazepines and Opiates in the Elderly: Use, Misuse, and AbuseAPA Committee on Access and Effectiveness of Psychiatric Services for the Elderly; Chairperson: Allan A. Anderson, M.D.

CW28. Re-Engineering Clinical Research Training: The NPTCAPA Council on Research; Co-Chairpersons: John F. Greden, M.D., James F. Leckman, M.D.

CW29. I Do, But I Can't: Mental Health Issues Around Gay MarriageAPA Committee on Gay, Lesbian, and Bisexual Issues; Chairperson: Serena Yuan Volpp, M.D.

CW30. Quotes and Misquotes: Resident Physicians Working With the MediaAPA Committee of Residents and Fellows and the APA Office of Communications and Public Affairs; Co-Chairpersons: William C. Wood, M.D., Hillarie Turner

CW31. Practicing Rewarding Psychiatry in Jails and Prisons: A PracticumAPA Caucus of Psychiatrists Working in Correctional Settings; Chairperson: Henry C. Weinstein, M.D.

CW32. The Voice of APA Past and Present: Considerations for an Oral History ProjectAPA Corresponding Committee on History and Library; Chairperson: Avram H. Mack, M.D.

CW33. When It's Not All in Your Head: Health, Mental Illness, Ethnicity, and RecoveryAPA Council on Social Issuesand Public Psychiatry; Co-Chairpersons: Robert P. Cabaj, M.D., Matthew O. Hurford, M.D.

+

IW44. Topics in Psychosomatic Medicine: Fatigue in Cancer and AIDSCo-Chairpersons: William Breitbart, M.D., Andrew J. Roth, M.D.; Collaborative Session With the National Institute of Mental Health

IW45. How to Launch a Successful Private Practice (Part 2)Co-Chairpersons: William E. Callahan Jr., M.D., Keith W. Young, M.D.

IW46. Strategies for Success for Early Career Academic Psychiatrists (Part 2): PromotionChairperson: Laura W. Roberts, M.D.; Collaborative Session With the National Institute of Mental Health

IW47. Responding to the Impact of Suicide on CliniciansChairperson: Eric M. Plakun, M.D.

IW48. Cannabis-Dependence Treatment: Where We Are, Where We Are GoingNational Institute on Drug Abuse; Chairperson: Francis J. Vocci, Ph.D.

IW49. Boundaries and Supervision: Avoiding Legal Risks and Doing Good Clinical WorkChairperson: Werner Tschan, M.D.

IW50. Psychiatric Comorbidities in HIV InfectionChairperson: David Stoff, Ph.D.; Collaborative Session With the National Institute of Mental Health

IW51. Renewing Integrity Through Film: An Essential Virtue of ProfessionalismChairperson: Francis G. Lu, M.D.

IW52. The Long-Term Effects of Violence in Shaping Minority CommunitiesCo-Chairpersons: Napoleon B. Higgins Jr., M.D., Aruna S. Rao, M.D.

IW53. The Movies and the MindChairperson: Willem C. Tuinebreijer

IW54. American Indian Telepsychiatry: Bridging Culture and DistanceChairperson: James H. Shore, M.D.

IW55. Chronic Fatigue Syndrome and Gulf War Illness: Pathology or Abnormal Illness Behavior?Chairperson: Peter Manu, M.D.

IW56. Computer-Assisted CBT in Education and TreatmentChairperson: Jesse H. Wright, M.D.

Noon-1:30 p.m.

+

4. Psychiatric Management of Treatment-Resistant SchizophreniaCo-Chairpersons: John S. McIntyre, M.D., Darrel A. Regier, M.D.

5. How Psycho-Oncology Came to BeChairperson: Philip R. Muskin, M.D.

6. Identity as Psychiatrists: Heritage and Creativity in This Unique SpecialtyCo-Chairpersons: Carlyle H. Chan, M.D., Charles Raison, M.D.

Noon-2 p.m.

New Research Poster Session 6

1 p.m.-5 p.m.

CME Courses 73-79

2 p.m.-3:30 p.m.

Lectures

L14. Genes, Cognition, and EmotionDaniel R. Weinberger, M.D., Frontiers of Science Lecture Series; Collaborative Session With the National Institute of Mental Health

L15. The Federal Regulation of Biomedical Research: A Study in Quid Pro QuosRobert P. Charrow, Esq.

L16. Eating Disorders in Middle and Late Life: Diagnosis and Treatment of a Neglected ProblemKathryn J. Zerbe, M.D., APA's Alexandra Symonds Award Lecture

2 p.m.-5 p.m.

+

3. Toward an Integrated Subspecialty of Psychosomatic MedicineAmerican Psychosomatic Society; Chairperson: Richard D. Lane, M.D.

4. Mental Health and Sub-Saharan Africa: A 21st-Century PerspectiveWorld Psychiatric Association; Co-Chairpersons: Michelle B. Riba, M.D., Ahmed M.F. Okasha, M.D.

+

S27. Neuroscience for the Psychiatrist (Part 1): Neuroimaging From Genomics to TherapyCollaborative Session With the National Institute of Mental Health

A. Imaging Genomics in Psychiatry Andreas Meyer-Lindenberg, M.D.

B. fMRI: Basics and Beyond Peter A. Bandettini, Ph.D.

C. Understanding Schizophrenia Using Functional Brain Imaging Cameron Carter, M.D.

D. Linking Imaging and Treatment Mechanisms for Depression Helen S. Mayberg, M.D.

S28. Real-Life Medical Management of HIV

A. HIV Treatment Update Khakasa H. Wapenyi, M.D.

B. Managing Mood Disorders Milton L. Wainberg, M.D.

C. Managing Hepatitis C, Syphilis, and HIV Infection Annette M. Matthews, M.D.

D. Managing Psychosis Shahrad R. Amiri, M.D.

E. Managing Metabolic Syndromes Marshall Forstein, M.D.

S29. Psychosomatic Medicine: Integrating Epidemiology, Psychiatry, and Medicine

A. Risk of Myocardial Infarction Associated With Panic Disorder Andres Gomez-Caminero, Ph.D.

B. The Prevalence of Depressive Disorders in Patients With Dementia in IHCIS Dimitri Bennett, M.D.

C. Diabetes and Lipid-Profile Risks With Neuroleptics: Two- to Five-Year Outcome Robert C. Joseph, M.D.

D. Somatic Complaints in Traumatized Children Ruby C. Castilla-Puentes, M.D.

E. A Case-Control Study of Erectile Dysfunction Among Men Diagnosed With Panic Disorder William Blumentals, Ph.D.

S30. The Art and Science of Brief Therapies

A. Expectancy, the Ignored Common Factor: Creating Hope in Psychotherapy Roger P. Greenberg, Ph.D.

B. Solution-Focused Brief Therapy: Doing What Works Brett Steenbarger, Ph.D.

C. Brief Interpersonal Therapy Scott Stuart, M.D.

D. Cognitive Therapy: Practice and Training Judith S. Beck, Ph.D.

S31. Posttraumatic Stress and Medical Illness: Interdisciplinary Perspectives

A. PTSD in Medically Ill Adults and Children: A Review Eyal Shemesh, M.D.

B. PTSD Symptoms in Children Who Had Transplants: One Center's Experience Sukru Emre, M.D.

C. The Study of PTSD in the Medically Ill: Choice of Outcome Measures Gad Cotter, M.D.

D. The National Child Traumatic Network Medical Trauma Toolkit Margaret L. Stuber, M.D.

S32. Medical Comorbidity in the U.S. and France: Vive La Difference!French Federation of Psychiatry

A. Mortality in a Cohort of Patients With Schizophrenia Frederic Limosin, M.D.

B. Prevalence, Treatment, and Prevention of HIV/Hepatitis in the U.S. Lisa B. Dixon, M.D.

C. Adverse Metabolic Effects of Antipsychotics in Schizophrenia Marie France Poirier, M.D.

D. Diabetes and Other Metabolic Disorders in Schizophrenia Michael J. Sernyak, M.D.

E. The Impact of Smoking in Patients With Schizophrenia Alain Dervaux, M.D.

F. Medical Comorbidities and Health Behaviors: Smoking, Exercise, and Weight Gail L. Daumit, M.D.

S33. Medical and Psychiatric Issues in the Mexican-American Population in the U.S.

A. Health Status of Mexican Americans Michael P. Stern, M.D.

B. Depression as Comorbid Condition With Type-2 Diabetes in a U.S.-Mexico Border Community Clinic Roberto Villarreal, M.D.

C. Insights on Schizophrenia in Three Countries Rolando A. Medina, M.D.

S34. Atypical Antipsychotics: Treatment of Agitation Across Mental Disorders

A. Treatment of Agitation With Atypical Antipsychotics in Schizophrenia Stephen R. Marder, M.D.

B. Treatment of Agitation With Atypical Antipsychotics in Bipolar Affective Disorder Gary S. Sachs, M.D.

C. Treatment of Agitation With Atypical Antipsychotics in Alzheimer's Disease Jacobo E. Mintzer, M.D.

D. Assessing the Data in the Context of Clinical Care Eric D. Caine, M.D.

S35. The Many Faces of Depression: Do Antidepressants Treat Different Symptoms?

A. Do Antidepressants Treat Different Core Symptoms of Depression? J. Craig Nelson, M.D.

B. Anger Attacks in Depression: Does 5HT Matter? Maurizio Fava, Ph.D.

C. Positive and Negative Affect and Antidepressant Response Pedro L. Delgado, M.D.

D. How Do Antidepressants Affect the Processing of Posistive and Negative Emotional Information? Catherine J. Harmer, D.Phil.

E. The Role of Dopamine in Depression: Implications for Treatment Anthony J. Rothschild, M.D.

S36. Understanding and Treating Alcohol Dependence

A. Neuropharmacological Basis of Alcohol Dependence George F. Koob, Ph.D.

B. New Pharmacological Strategies for Treating Alcohol Dependence Barbara J. Mason, Ph.D.

C. Recent Developments in the Genetics of Alcohol Dependence Marc A. Schuckit, M.D.

D. New Medications: The Use of Anticonvulsants, Both Alone and in Combination With Various Forms of Psychotherapy Bankole A. Johnson, M.D.

E. Differential Effects of Pharmacological Agents on Craving Nassima Ait-Daoud, M.D.

S37. Evidence-Based Psychiatry: What It Is and What It Is Not

A. Evidence-Based Medicine in Psychiatry: An Overview Gregory E. Gray, M.D.

B. Evidence-Based Approaches to Teaching and Practicing Psychopharmacology David N. Osser, M.D.

C. Uses and Abuses of EBM in Psychiatry S. Nassir Ghaemi, M.D.

D. Evidence-Based Medicine: How It Can Be Misused David T. Healy, M.D.

E. EBM and Pharmaceutical Industry-Sponsored Clinical Trials Amir H. Kalali, M.D.

S38. How to Launch a Successful Private Practice (Part 3)

A. Personal Factors Leading to a Successful Private Practice William E. Callahan Jr., M.D.

B. Office Location and Design for Efficiency and Success Keith W. Young, M.D.

C. Streamlining Overhead and Managing Your Business in Private Practice Keith W. Young, M.D. D. Marketing Your Unique Private Practice William E. Callahan Jr., M.D.

S39. Complex Pharmacotherapy Versus Polypharmacy

A. Polypharmacy and Ethnic Minorities William Lawson, M.D.

B. Impulsive Behavior in Children and Adolescents Janice G. Hutchinson, M.D.

C. Polypharmacy in Depression and Anxiety: What, When, and How to Implement Gabriela Cora-Locatelli, M.D.

D. Complexities of Bipolar Illness Typically Require Complex Combination Therapy Robert M. Post, M.D.

E. Polypharmacy in Schizophrenia Treatment David C. Henderson, M.D.

S40. Integrating and Sequencing Treatments for Borderline Patients

A. Phases and Stages of Change in the Treatment of Personality Disorder John Livesley, Ph.D.

B. Adapting Dialectical Behavior Therapy for the Psychiatric Practitioner Barbara H. Stanley, Ph.D.

C. Common Mechanisms in Psychological Theories: Attachment and Mentalization Peter Fonagy, Ph.D.

D. Toward a Rational Pharmacotherapy of BPD Larry J. Siever, M.D.

E. Psychoeducation for Family Members With a Relative With BPD Perry D. Hoffman, Ph.D.

S41. Maternal Depression and Comorbidities: Impact on Infants

A. Maternal Depression and Comorbidities: PTSD and BPD Marian I. Butterfield, M.D.

B. Perinatal Depression: Impact of Maternal Distress on Neonatal Outcomes and Attachment Sheila M. Marcus, M.D.

C. Impact of Maternal BPD on Infant Emotional Regulation Gisèle Apter-Danon, Ph.D.

D. How Early Life Experience Affects the Development of Optimism's Neural Circuitry Susan C. Vaughan, M.D.

S42. ADHD: From Neuroscience to PracticeCollaborative Session With the National Institute of Mental Health

A. Psychiatric and Functional Outcome of Adolescent Females With ADHD: A Large, Controlled, Five-Year Longitudinal Follow-Up Study Joseph Biederman, M.D.

B. Nonstimulant Treatment of Adult ADHD Thomas J. Spencer, M.D.

C. Neuropsychology of ADHD: Clinical and Scientific Implications of Recent Findings Alysa E. Doyle, Ph.D.

D. Heritability: New Genetic Findings in ADHD Pamela Sklar, M.D.

E. Looking at the ADHD Brain: Neuroimaging Studies in ADHD Larry J. Seidman, Ph.D.

S43. Associations Between Stress/Anxiety and Personality Styles and DisordersAssociation for Research in Personality Disorders

A. A Selective Overview of Relationship of Anxiety and Personality Disorders James H. Reich, M.D.

B. Schema Therapy for Maladaptive Personality Traits Involving Anxiety David Bernstein

C. Personality and Stress in Three Phases of the Physician's Career: A Longitudinal Nationwide Study Per Vaglum, M.D.

D. Panic, Rage, and Family Discord in BPD David M. Allen, M.D.

E. Is Emotional Dyscontrol and Impulsivity Related to Suicidal Ideation in BPD Patients? Navjot Chaudhary, B.S.C.

F. Stress, Personality Disorders, and Opioid Receptors Kenneth Silk, M.D.

S44. Perinatal Depression: Prevalence, Screening Accuracy, and Intervention

A. A Systematic Review of the Evidence on the Incidence and Prevalence of Perinatal Depression Norma I. Gavin, Ph.D.

B. What Is the Accuracy of Different Screening Tools for Detecting Depression During the Perinatal Period? Bradley N. Gaynes, M.D.

C. Does Perinatal Screening for Depressive Symptoms With Subsequent Intervention Lead to Improved Outcomes? A Systematic Review of the Evidence Samantha E. Meltzer-Brody, M.D.

S45. The Long-Term Psychological Aftermath of 9/11-Related Traumatic Loss

A. Traumatic Grief Among 9/11 Victims Yuval Y. Neria, Ph.D.

B. Trauma, Bereavement, and Traumatic Loss George A. Bonanno, Ph.D.

C. A Nationwide Longitudinal Study of Responses to the 9/11 Terrorist Attacks Roxane C. Silver, Ph.D.

D. Loss and Consequences After Mass Trauma: Examples From the 9/11 Terrorist Attacks in New York City Sandro Galea, M.D.

E. 9/11-Related Traumatic Loss and Its Psychopathology in Primary Care Patients in New York City Raz Gross, M.D.

S46. Rehabilitation of the Mad or Bad: GloballyAmerican Association for Psychosocial Rehabilitation and the World Psychiatric Association's Section on Rehabilitation

A. Mad or Bad? Japan Naotaka Shinfuku, M.D.

B. Mad or Bad? United States Zebulon Taintor, M.D.

C. Mad or Bad? Hungary Ida Kosza, M.D.

D. Mad or Bad? Pakistan Afzal Javed, M.D.

E. Mad or Bad? International Efforts Humberto Martinez, M.D.

S47. New Developments in the Treatment of Somatoform Disorders

A. Pharmacotherapy of Somatoform Disorders Brian A. Fallon, M.D.

B. Managing Common Somatic Presentations in Primary Care: Cultural Considerations Javier I. Escobar, M.D.

C. Cognitive-Behavior Therapy for Hypochondriasis: A Randomized, Controlled Intervention Trial Arthur J. Barsky, M.D.

D. Treatment of Unexplained Somatic Symptoms in Children and Adolescents Joshua D. Lipsitz, Ph.D.

E. Integrative Treatment for Fibromyalgia/Chronic Fatigue Syndrome Richard P. Brown, M.D.

S48. Inpatient Psychiatry: Crisis and Response

A. Public Policy and Inpatient Psychiatric Care Anita S. Everett, M.D.

B. An Updated Model for Inpatient Psychiatric Care Ira D. Glick, M.D.

C. Crisis Residential Care for Patients With Serious Mental Illness: Outcomes and Cost Wayne S. Fenton, M.D.

D. A National Referral Center for Treatment-Resistant Patients Edward R. Shapiro, M.D.

E. Trends and Characteristics of Inpatient Treatment in Routine Psychiatric Practice in the U.S. Joshua E. Wilk, Ph.D.

S49. Advances and Innovations in Assessing Decision-Making Capacity

A. Evaluating Decisional Capacity in Older Patients Barton W. Palmer, Ph.D.

B. Error Behaviors in Capacity Interviews Scott Y. Kim, M.D.

C. Distinguishing Research From Clinical Care Laura B. Dunn, M.D.

D. Capacity for Informed Consent in Patients With Schizophrenia David J. Moser, Ph.D.

S50. Novel Research Treatments for Eating DisordersCollaborative Session With the National Institute of Mental Health

A. Atypical Antipsychotic Medication for Anorexia Nervosa Evelyn Attia, M.D.

B. New Medication Treatments for Binge-Eating Disorder Jose C. Appolinario, M.D.

C. CD-ROM-Based Treatment for Binge-Eating Disorder and Obesity Cynthia M. Bulik, Ph.D.

D. How the Study of Mechanism May Inform Treatment of Bulimia Nervosa B. Timothy Walsh, M.D.

E. D-Cycloserine and Anorexia Nervosa: Clinical Implications of Translational Research Joanna E. Steinglass, M.D.

S51. Neuroscience and Dynamic PsychiatryAmerican Academy of Psychoanalysis and Dynamic Psychiatry

A. Psychotherapy and Neurobiology Richard M. Brockman, M.D.

B. Contemporary Affect Theory and Controversies Regarding Drive Theory in Psychoanalysis Otto F. Kernberg, M.D.

C. Imaging the Mind-Brain Interface Bridging the Psychoanalysis-Neuroscience Gap David A. Silbersweig, M.D.

D. How Neuroscience Can Help the Clinician Samuel Slipp, M.D.

S52. Disturbed Fronto-Limbic Brain Circuitry: How Specific Is It for Different Psychiatric Disorders?

A. Fronto-Limbic Brain Pathology: Evidence From Animal Research Gregory Quirk, Ph.D.

B. Fronto-Limbic Brain Pathology in PTSD Eric Vermetten, M.D.

C. Prefrontal and Limbic Pathology in BPD Klaus Lieb, M.D.

D. Stress-Induced Brain Structural Plasticity: What Do Animal Models Tell Us? Bruce S. McEwen, Ph.D.

E. Neural Circuits in Trauma Spectrum Disorders J. Douglas Bremner, M.D.

S53. Increases in Opioid Analgesic Abuse: Concerns and StrategiesNational Institute on Drug Abuse

A. Increases in Opioid Analgesic Use, Misuse, and Addiction Wilson M. Compton III, M.D.

B. The Availability of Opioid Medications Over the Internet Without a Prescription Robert F. Forman, Ph.D.

C. Managing Chronic Pain in the Patient With Comorbid Substance Abuse Nathaniel P. Katz, M.D.

D. Treatment of Prescription Analgesic Abuse Herbert D. Kleber, M.D.

S54. Psychiatry and the Pharmaceutical Industry: Where Is the Boundary?

A. Pharmaceutical Promotions: Effects on the Practice of Psychiatry Amy C. Brodkey, M.D.

B. Academic Medicine, Medical Education, and the Pharmaceutical Industry Frederick S. Sierles, M.D.

C. The Pharmaceutical Industry, Psychiatry, and the Public Interest Robert M. Factor, M.D.

D. Dancing With Porcupines: Dilemmas Faced by Speakers for the Pharmaceutical Industry Diana M. Koziupa, M.D.

S55. Autism: A Common, Severe, Treatable, and Neglected Psychiatric IllnessCollaborative Session With the National Institute of Mental Health

A. A Comprehensive Review of Major Research Findings in Autism From the Past Decade Eric B. London, M.D.

B. Biology of Social Behavior From Mice to Monkeys James T. Winslow, Ph.D.

C. fMRI Studies of Social Perception and Social Cognition in Autistic Disorder Robert T. Schultz, Ph.D.

D. Targeted Treatments for the Repetitive Behavior Domain in Autism Eric Hollander, M.D.

E. Atypical Antipsychotics in Children With Pervasive Developmental Disorders Lawrence Scahill, Ph.D.

2 p.m.-5:30 p.m.

Review of Psychiatry (Section 1): Sleep Disorders and PsychiatryChairperson: Daniel J. Buysse, M.D.

1. Insomnia Daniel J. Buysse, M.D.

2. Sleep-Related Breathing Disorders Patrick J. Strollo, M.D.

3. Restless Leg Syndrome and Parasomnias John W. Winkelman, M.D.

4. Circadian Rhythm Sleep Disorders Phyllis C. Zee, M.D.

3 p.m.-5 p.m.

New Research Poster Session 7

6 p.m.-8 p.m.

Special Session

Global Disasters: Psychiatric Medicine and Public Health ChallengesAPA Council on Global Psychiatry and World Psychiatric Association Conflict Management and Conflict Resolution Section, Co-Chairpersons: Rodrigo A. Muñoz, M.D., Eliot Sorel, M.D.; Presenters: Srinivan Murthy, M.D., M. Paramsheva Deva, M.D., Lennart Levi, M.D.; Discussants: Professor Mordechai Benyakar, Anthony T. Ng, M.D.

7 p.m.-10 p.m.

Industry-Supported Symposia

IS39. Seasonal Affective Disorder: New Concepts, Practical StrategiesSupported by GlaxoSmithKline

A. The Clinical Picture and Epidemiology of SAD Norman E. Rosenthal, M.D.

B. Pathophysiology of Seasonal Affective Disorder Thomas A. Wehr, M.D.

C. Light Treatment for Winter Depression: Status Report Raymond W. Lam, M.D.

D. Medical Treatment Including Mechanism of Action: New Study Data Jennifer K. Pennell, M.D.

E. Integrating Cognitive-Behavioral Therapy Into Seasonal Affective Disorder Treatment Kelly J. Rohan, Ph.D.

IS40. Alcoholism: Translating Emerging Science Into Clinical PracticeSupported by Alkermes

A. Animal Models Point the Way to Novel Therapies George F. Koob, Ph.D.

B. Brain Imaging of Craving and the Effects of Anticraving Medications Charles P. O'Brien, M.D.

C. Advances in the Pharmacotherapy of Alcoholism Helen M. Pettinati, Ph.D.

D. Alcoholism and Other Psychiatric Disorders: How Do We Manage Dual Diagnosis? Hugh Myrick, M.D.

IS41. Advances in Cholinergic Therapy: Alzheimer's Disease and BeyondSupported by Eisai Inc.

A. Revisiting the Cholinergic Hypothesis: Are Cholinesterase Inhibitors More Than Symptomatic Treatments for Alzheimer's Disease? Norman Relkin, M.D.

B. The Role of Imaging in the Study and Treatment of Dementia K. Ranga R. Krishnan, M.D.

C. Clinical Trials in Cognitive Impairment Ronald C. Petersen, M.D.

D. Pharmacological Treatment of Cognitive Impairments in Schizophrenia Robert W. Buchanan, M.D.

E. Behavioral Disturbances in Alzheimer's Disease: Diagnosis and Management Helen Lavretsky, M.D.

IS42. Challenges at the Interface of Psychiatric, Medical, and Sleep DisordersSupported by Sanofi-Synthelabo Inc.

A. Epidemiological and Longitude Perspectives on Insomnia and Psychiatric Illness Daniel E. Ford, M.D.

B. Changing Women's Sleep Vulnerabilities Across the Life Cycle Lois Krahn, M.D.

C. Sleep Disturbances and Neurodegenerative Disorders Raymond R. Auger, M.D.

D. Metabolic Consequences of Insomnia: Implications for Medicine and Psychiatry Gary S. Richardson, M.D.

E. Therapeutic Challenges in Treating Insomnia With Comorbid Psychiatric and Medical Disorders David N. Neubauer, M.D.

IS43. It's Not Just for Kids: ADHD in Adolescence and AdulthoodSupported by Shire US Inc.

A. The Course of ADHD From Adolescence Into Adulthood Christopher J. Kratochvil, M.D.

B. Neurobiological Update on ADHD in Adolescence and Adulthood Stephen V. Faraone, Ph.D.

C. New Psychotherapies Directed at Young Adults With ADHD Steven A. Safren, Ph.D.

D. College Considerations in Young Adults With ADHD Sharon B. Wigal, Ph.D.

E. Medication Considerations in Young Adults With ADHD Timothy Wilens, M.D.

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles
Articles